Unilever PLC - ULVR.L

ULVR.L Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ULVR.L	0.1	2.7	0.7	-5.0	2.1	24.2	25.6	4.3	69.2	535.5
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare ULVR.L with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ULVR.L
name	Unilever PLC
price	4589.5
changes percentage	0.0545
change	2.5
day low	4564
day high	4593
year high	5034
year low	3680.5
market cap	113615345496
price avg 50	4588.32
price avg 200	4556.445
exchange	LSE
volume	191714
avg volume	3361415
open	4565
previous close	4587
eps	2.22
pe	20.67
earnings announcement	2025-02-13T07:00:00.000+0000
shares outstanding	2475549526
timestamp	2025-01-20 08:55:22

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 39.3%

Overall Quarterly Financial Health: 62.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	59604000000	60073000000	-0.78
gross profit	25175000000	24167000000	4.17
gross profit ratio	0.42	0.4	4.99
research and development expenses	949000000	908000000	4.52
operating expenses	15417000000	14440000000	6.77
interest income	442000000	281000000	57.30
interest expense	1075000000	818000000	31.42
ebitda	11992000000	13072000000	-8.26
ebitdaratio	0.2	0.22	-7.74
operating income	9758000000	10755000000	-9.27
operating income ratio	0.16	0.18	-8.56
net income	6487000000	7642000000	-15.11
net income ratio	0.11	0.13	-14.45
eps	2.56	2.92	-12.33

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 59,604 million in 2023 from 60,073 million in 2022 representing a change of -0.78%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 15,417 million in 2023 from 14,440 million in 2022 representing a change of 6.77%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 11,992 million in 2023 from 13,072 million in 2022 representing a change of -8.26%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 6,487 million in 2023 from 7,642 million in 2022 representing a change of -15.11%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.56 in 2023 from 2.56 in 2022 representing a change of -12.33%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 25,175 million in 2023 from 24,167 million in 2022 representing a change of 4.17%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 949 million in 2023 from 908 million in 2022 representing a change of 4.52%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 9,758 million in 2023 from 10,755 million in 2022 representing a change of -9.27%. The increase in operating income indicates better operational performance and increased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	31117000000	29176000000	6.65
gross profit	31117000000	-5253000000	692.37
gross profit ratio	1	-0.18	655.42
research and development expenses	0	949000000	-100.00
operating expenses	25169000000	9649000000	160.85
interest income	393000000	403993794	-2.72
interest expense	0	899490456	-100.00
ebitda	6917000000	5029000000	37.54
ebitdaratio	0.22	0.17	28.96
operating income	5948000000	4793000000	24.10
operating income ratio	0.19	0.16	16.36
net income	3701000000	2939000000	25.93
net income ratio	0.12	0.1	18.07
eps	1.47	1.16	26.72

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 31,117 million in 2024Q2 from 29,176 million in 2023Q4 representing a change of 6.65%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 31,117 million in 2024Q2 from -5,253 million in 2023Q4 representing a change of 692.37%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 25,169 million in 2024Q2 from 9,649 million in 2023Q4 representing a change of 160.85%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 6,917 million in 2024Q2 from 5,029 million in 2023Q4 representing a change of 37.54%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 5,948 million in 2024Q2 from 4,793 million in 2023Q4 representing a change of 24.1%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3,701 million in 2024Q2 from 2,939 million in 2023Q4 representing a change of 25.93%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.47 in 2024Q2 from 1.47 in 2023Q4 representing a change of 26.72%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 949 million in 2023Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	75266000000	77821000000	-3.28
total liabilities	54502000000	56120000000	-2.88
total equity	20764000000	21701000000	-4.32
cash and cash equivalents	4159000000	4326000000	-3.86
short term investments	1950000000	1197000000	62.91
long term investments	1220000000	-293000000	516.38
total current assets	17902000000	19157000000	-6.55
total non current assets	57364000000	58664000000	-2.22
total current liabilities	23507000000	25427000000	-7.55
total non current liabilities	30995000000	30693000000	0.98
common stock	88000000	92000000	-4.35
retained earnings	47052000000	50253000000	-6.37
total debt	28593000000	28439000000	0.54

Overall Score of Annual Balance Sheet

0.3 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 75,266 million in 2023 from 77,821 million in 2022 representing a change of -3.28%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 20,764 million in 2023 from 21,701 million in 2022 representing a change of -4.32%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 4,159 million in 2023 from 4,326 million in 2022 representing a change of -3.86%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 17,902 million in 2023 from 19,157 million in 2022 representing a change of -6.55%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 88 in 2023 from 92 in 2022 representing a change of -4.35%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to 47,052 million in 2023 from 50,253 million in 2022 representing a change of -6.37%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 28,593 million in 2023 from 28,439 million in 2022 representing a change of 0.54%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 54,502 million in 2023 from 56,120 million in 2022 representing a change of -2.88%. This indicates a decrease in overall liabilities.

  Short Term Investments: Short Term Investments increased to 1,950 million in 2023 from 1,197 million in 2022 representing a change of 62.91%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 23,507 million in 2023 from 25,427 million in 2022 representing a change of -7.55%. This indicates a lower short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	79832000000	75266000000	6.07
total liabilities	56809000000	54502000000	4.23
total equity	23023000000	20764000000	10.88
cash and cash equivalents	4970000000	4159000000	19.50
short term investments	896000000	1950000000	-54.05
long term investments	1294000000	-545000000	337.43
total current assets	20221000000	17902000000	12.95
total non current assets	59611000000	57364000000	3.92
total current liabilities	26130000000	23507000000	11.16
total non current liabilities	30679000000	30995000000	-1.02
common stock	88000000	88000000	0.00
retained earnings	49567000000	47052000000	5.35
total debt	31654000000	28593000000	10.71

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 79,832 million in 2024Q2 from 75,266 million in 2023Q4 representing a change of 6.07%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 23,023 million in 2024Q2 from 20,764 million in 2023Q4 representing a change of 10.88%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 4,970 million in 2024Q2 from 4,159 million in 2023Q4 representing a change of 19.5%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 20,221 million in 2024Q2 from 17,902 million in 2023Q4 representing a change of 12.95%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 49,567 million in 2024Q2 from 47,052 million in 2023Q4 representing a change of 5.35%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 56,809 million in 2024Q2 from 54,502 million in 2023Q4 representing a change of 4.23%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 896 million in 2024Q2 from 1,950 million in 2023Q4 representing a change of -54.05%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 26,130 million in 2024Q2 from 23,507 million in 2023Q4 representing a change of 11.16%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 31,654 million in 2024Q2 from 28,593 million in 2023Q4 representing a change of 10.71%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-180000000	838000000	-121.48
operating cash flow	9426000000	7282000000	29.44
free cash flow	7681000000	5655000000	35.83
capital expenditure	-1745000000	-1627000000	-7.25
depreciation and amortization	1578000000	1946000000	-18.91
deferred income tax	0	0	NaN
stock based compensation	212000000	177000000	19.77
accounts payables	-768000000	1852000000	-141.47
inventory	340000000	-1398000000	124.32
acquisitions net	-268000000	3643000000	-107.36
investments in property plant and equipment	-1502000000	-1627000000	7.68
net cash used for investing activites	-2294000000	2453000000	-193.52
debt repayment	497000000	-1209000000	141.11
common stock issued	0	0	NaN
common stock repurchased	-1507000000	-1509000000	0.13
dividends paid	-4363000000	-4329000000	-0.79
net cash used provided by financing activities	-7193000000	-8890000000	19.09
cash at end of period	4045000000	4225000000	-4.26
accounts receivables	768000000	-1852000000	141.47
cash at beginning of period	4225000000	3387000000	24.74

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -180 million in 2023 from 838 million in 2022 representing a change of -121.48%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation increased to 212 million in 2023 from 177 million in 2022 representing a change of 19.77%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 768 in 2023 from -1,852 million in 2022 representing a change of 141.47%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -4,363 million in 2023 from -4,329 million in 2022 representing a change of -0.79%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 9,426 million in 2023 from 7,282 million in 2022 representing a change of 29.44%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 7,681 million in 2023 from 5,655 million in 2022 representing a change of 35.83%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -1,745 million in 2023 from -1,627 million in 2022 representing a change of -7.25%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 768 million in 2023 from 1,852 million in 2022 representing a change of -141.47%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	3364000000	6060000000	-44.49
free cash flow	2747000000	5106000000	-46.20
capital expenditure	-617000000	-954000000	35.32
depreciation and amortization	794000000	637000000	24.65
deferred income tax	0	0	NaN
stock based compensation	164000000	53000000	209.43
accounts receivables	-2159000000	768000000	-381.12
accounts payables	0	0	NaN
inventory	-435000000	340000000	-227.94
acquisitions net	-797000000	-1056000000	24.53
investments in property plant and equipment	-617000000	-954000000	35.32
net cash used for investing activites	-392000000	-2094000000	81.28
debt repayment	0	0	NaN
common stock issued	0	-1664316318	100.00
common stock repurchased	-375000000	-754000000	50.27
dividends paid	-2136000000	-2161000000	1.16
net cash used provided by financing activities	-2154000000	-4704000000	54.21
net change in cash	4854000000	-681675441	812.07
cash at end of period	404500000	3603890296	-88.78
cash at beginning of period	0	4285565737	-100.00

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 4,854 million in 2024Q2 from -682 million in 2023Q4 representing a change of 812.07%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Receivables: Accounts Receivables decreased to -2,159 million in 2024Q2 from 768 million in 2023Q4 representing a change of -381.12%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -2,136 million in 2024Q2 from -2,161 million in 2023Q4 representing a change of 1.16%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 3,364 million in 2024Q2 from 6,060 million in 2023Q4 representing a change of -44.49%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 2,747 million in 2024Q2 from 5,106 million in 2023Q4 representing a change of -46.2%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -617 million in 2024Q2 from -954 million in 2023Q4 representing a change of 35.32%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 164 million in 2024Q2 from 53 million in 2023Q4 representing a change of 209.43%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	23.52	23.57	-0.22
net income per share	2.56	3.0	-14.64
operating cash flow per share	3.72	2.86	30.17
free cash flow per share	3.03	2.22	36.59
cash per share	2.41	2.17	11.23
book value per share	8.19	8.52	-3.78
tangible book value per share	-7.38	-7.37	-0.10
shareholders equity per share	7.14	7.46	-4.30
interest debt per share	11.71	11.48	1.97
market cap	110908441718.75	120365985258	-7.86
enterprise value	135342441718.75	144478985258	-6.32
pe ratio	17.1	15.75	8.55
price to sales ratio	1.86	2.0	-7.13
pocfratio	11.77	16.53	-28.82
pfcf ratio	14.44	21.28	-32.16
pb ratio	6.13	6.33	-3.18
ptb ratio	6.13	6.33	-3.18
ev to sales	2.27	2.41	-5.59
enterprise value over ebitda	11.29	11.05	2.11
ev to operating cash flow	14.36	19.84	-27.63
ev to free cash flow	17.62	25.55	-31.03
earnings yield	0.06	0.06	-7.88
free cash flow yield	0.07	0.05	47.41
debt to equity	1.58	1.5	5.65
debt to assets	0.38	0.37	3.95
net debt to ebitda	2.04	1.84	10.46
current ratio	0.76	0.75	1.08
interest coverage	9.08	13.15	-30.96
income quality	1.32	0.88	49.91
dividend yield	0.04	0.04	9.38
payout ratio	0.67	0.57	18.73
sales general and administrative to revenue	0.1	0.1	0.68
research and ddevelopement to revenue	0.02	0.02	5.34
intangibles to total assets	0.52	0.52	0.78
capex to operating cash flow	0.19	0.22	-17.14
capex to revenue	0.03	0.03	8.10
capex to depreciation	1.11	0.84	32.26
stock based compensation to revenue	0.0	0.0	20.72
graham number	20.28	22.44	-9.62
roic	0.13	0.15	-11.29
return on tangible assets	0.18	0.2	-11.48
graham net net	-18.09	-17.35	-4.22
working capital	-5605000000	-6270000000	10.61
tangible asset value	-18702000000	-18788000000	0.46
net current asset value	-36600000000	-36963000000	0.98
invested capital	44568000000	44989000000	-0.94
average receivables	2272000000	4063000000	-44.08
average payables	10727500000	9998000000	7.30
average inventory	5525000000	5307000000	4.11
days sales outstanding	0	27.61	-100.00
days payables outstanding	109.78	112.84	-2.71
days of inventory on hand	54.27	60.29	-9.99
receivables turnover	0	13.22	-100.00
payables turnover	3.32	3.23	2.79
inventory turnover	6.73	6.05	11.10
roe	0.36	0.4	-10.80
capex per share	0.69	0.64	7.85

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.36 on 2023-12-31 from 0.40 on 2022-12-31, representing a change of -10.80%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 17.10 on 2023-12-31 from 15.75 on 2022-12-31, representing a change of 8.55%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio increased to 0.76 on 2023-12-31 from 0.75 on 2022-12-31, representing a change of 1.08%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Debt-to-Equity Ratio:

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
ULVR.L
calendar year	2024	2023	NaN
revenue per share	12.36	11.51	7.37
net income per share	1.47	1.16	26.77
operating cash flow per share	1.34	2.39	-44.12
free cash flow per share	1.09	2.01	-45.84
cash per share	2.33	2.41	-3.34
book value per share	9.14	8.19	11.62
tangible book value per share	-7.18	-7.38	2.69
shareholders equity per share	8.07	7.14	12.94
interest debt per share	12.57	11.64	8.05
market cap	128762717071.16	110932497706.76	16.07
enterprise value	155446717071.16	135366497706.76	14.83
pe ratio	8.7	9.44	-7.83
price to sales ratio	4.14	3.8	8.83
pocfratio	38.28	18.31	109.10
pfcf ratio	46.87	21.73	115.75
pb ratio	6.34	6.13	3.46
ptb ratio	6.34	6.13	3.46
ev to sales	5.0	4.64	7.67
enterprise value over ebitda	22.47	26.92	-16.51
ev to operating cash flow	46.21	22.34	106.86
ev to free cash flow	56.59	26.51	113.45
earnings yield	0.03	0.03	8.49
free cash flow yield	0.02	0.05	-53.65
debt to equity	1.56	1.58	-1.32
debt to assets	0.4	0.38	4.37
net debt to ebitda	3.86	4.86	-20.60
current ratio	0.77	0.76	1.62
interest coverage	0	5.33	-100.00
income quality	0.91	2.06	-55.92
dividend yield	0.02	0.02	-14.84
payout ratio	0.58	0.74	-21.51
sales general and administrative to revenue	0	0.23	-100.00
research and ddevelopement to revenue	0	0.03	-100.00
intangibles to total assets	0.51	0.52	-1.81
capex to operating cash flow	0.18	0.16	16.51
capex to revenue	0.02	0.03	-39.36
capex to depreciation	0.78	1.5	-48.11
stock based compensation to revenue	0.01	0.0	190.13
graham number	16.33	13.65	19.65
roic	0.07	0.07	3.36
return on tangible assets	0.1	0.08	16.40
graham net net	-16.76	-16.89	0.81
working capital	-5909000000	-5605000000	-5.42
tangible asset value	-18078000000	-18702000000	3.34
net current asset value	-36588000000	-36600000000	0.03
invested capital	46290000000	44568000000	3.86
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	22.92	12.41	84.70
days payables outstanding	0	27.07	-100.00
days of inventory on hand	0	13.38	-100.00
receivables turnover	3.93	7.25	-45.86
payables turnover	0	3.32	-100.00
inventory turnover	0	6.73	-100.00
roe	0.18	0.16	12.25
capex per share	0.25	0.38	-34.89

• Positive

  ROE: Return on Equity (ROE) increased to 0.18 on 2024-06-30 Q2 from 0.16 on 2023-12-31 Q4, representing a change of 12.25%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 8.70 on 2024-06-30 Q2 from 9.44 on 2023-12-31 Q4, representing a change of -7.83%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 0.77 on 2024-06-30 Q2 from 0.76 on 2023-12-31 Q4, representing a change of 1.62%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 8197.29 which is higher than current price 4589.5, indicates the company may be undervalued.